title: Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa.
authors: David T
authors: DT
authors: Woodley
authors: Xinyi
authors: X
authors: Wang
authors: Mahsa
authors: M
authors: Amir
authors: Brian
authors: B
authors: Hwang
authors: Jennifer
authors: J
authors: Remington
authors: Yingpin
authors: Y
authors: Hou
authors: Jouni
authors: J
authors: Uitto
authors: Douglas
authors: D
authors: Keene
authors: Mei
authors: M
authors: Chen
mesh_terms: D000818:Animals; D024143:Collagen Type VII / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D016108:Epidermolysis Bullosa Dystrophica / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D007275:Injections, Intravenous; D007365:Intercellular Junctions / Q000187:drug effects; D051379:Mice; D018345:Mice, Knockout; D008819:Mice, Nude; D010641:Phenotype; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D016038:Skin Transplantation; D016896:Treatment Outcome; D014947:Wounds and Injuries / Q000188:drug therapy* / Q000473:pathology
chemical_list: D024143:Collagen Type VII; D011994:Recombinant Proteins